Donggeon Kim
Overview
Explore the profile of Donggeon Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cho J, Kim D, Kim D, Kim T, Kim T, Pak C, et al.
J Reconstr Microsurg
. 2024 Nov;
PMID: 39496315
Background: This research aims to validate the proficiency and accuracy of the robotic microsurgery platform using rat femoral vessel model. Methods: A total of 256 rat femoral vessels were performed,...
2.
Lee D, Kim D, Kim D, Kang J, Lee K, Lee H, et al.
Mol Cancer Ther
. 2024 Aug;
24(2):176-187.
PMID: 39148331
Although cancer immunotherapy has yielded encouraging outcomes in hematologic malignancies, it has faced challenges in achieving the same level of effectiveness in numerous solid tumors, primarily because of the presence...
3.
Lee D, Kim D, Kim D, Kim N, Nam Y, Lee B, et al.
Int Immunopharmacol
. 2024 Jul;
139:112600.
PMID: 39002524
Immunotherapy has emerged as a promising approach to cancer treatment that utilizes the potential of the immune system to precisely identify and eradicate cancerous cells. Despite significant progress in immunotherapy,...
4.
Lee Y, Kim D, Chung P, Lee M, Kim N, Chang J, et al.
Ophthalmol Ther
. 2024 Jun;
13(8):2227-2242.
PMID: 38907092
Introduction: KNP-301 is a bi-specific fragment crystallizable region (Fc) fusion protein, which inhibits both C3b and vascular endothelial growth factor (VEGF) simultaneously for patients with late-stage age-related macular degeneration (AMD)....
5.
Cho Y, Jeong H, Shin H, Pak C, Cho J, Kim Y, et al.
Adv Sci (Weinh)
. 2023 Oct;
10(35):e2303728.
PMID: 37840396
Intuitive and perceptual neuroprosthetic systems require a high degree of neural control and a variety of sensory feedback, but reliable neural interfaces for long-term use that maintain their functionality are...
6.
Nam Y, Koo H, Yang Y, Shin S, Zhu Z, Kim D, et al.
Genome Med
. 2023 Mar;
15(1):16.
PMID: 36915208
Background: Although temozolomide (TMZ) has been used as a standard adjuvant chemotherapeutic agent for primary glioblastoma (GBM), treating isocitrate dehydrogenase wild-type (IDH-wt) cases remains challenging due to intrinsic and acquired...
7.
Lee T, Kim D, Kim T, Pak C, Suh H, Hong J
J Plast Reconstr Aesthet Surg
. 2022 Aug;
75(10):3859-3868.
PMID: 36041975
Background: High-intensity focused ultrasound (HIFU) therapy has emerged as an option for skin rejuvenation. However, the application against photo-damaged skin remains obscure. This study evaluates the effect of HIFU against...
8.
Choi S, Lee Y, Shin K, Koo H, Kim D, Sa J, et al.
Cell Death Dis
. 2021 Apr;
12(4):374.
PMID: 33828082
PTEN is one of the most frequently altered tumor suppressor genes in malignant tumors. The dominant-negative effect of PTEN alteration suggests that the aberrant function of PTEN mutation might be...
9.
Han S, Shin H, Lee J, Liu Z, Rabadan R, Lee J, et al.
Exp Mol Med
. 2020 Nov;
52(11):1869.
PMID: 33149237
No abstract available.
10.
Lee K, Koo H, Kim Y, Kim D, Son E, Yang H, et al.
Cancers (Basel)
. 2020 Nov;
12(11).
PMID: 33142709
We aimed to evaluate the preclinical efficacy of GC1118, a novel anti-epidermal growth factor receptor (EGFR) monoclonal antibody (mAb), against glioblastoma (GBM) tumors using patient-derived xenograft (PDX) models. A total...